Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000200002 |
Resumo: | The aim of this study was to present the contributions of the systematic review of economic evaluations to the development of a national study on childhood hepatitis A vaccination. A literature review was performed in EMBASE, MEDLINE, WOPEC, HealthSTAR, SciELO and LILACS from 1995 to 2010. Most of the studies (8 of 10) showed favorable cost-effectiveness results. Sensitivity analysis indicated that the most important parameters for the results were cost of the vaccine, hepatitis A incidence, and medical costs of the disease. Variability was observed in methodological characteristics and estimates of key variables among the 10 studies reviewed. It is not possible to generalize results or transfer epidemiological estimates of resource utilization and costs associated with hepatitis A to the local context. Systematic review of economic evaluation studies of hepatitis A vaccine demonstrated the need for a national analysis and provided input for the development of a new decision-making model for Brazil. |
id |
FIOCRUZ-5_9538fca60b14c953585655227c87f6fb |
---|---|
oai_identifier_str |
oai:scielo:S0102-311X2012000200002 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in BrazilCost-Effectiveness EvaluationCost-Benefit AnalysisHepatitis AImmunization ProgramsThe aim of this study was to present the contributions of the systematic review of economic evaluations to the development of a national study on childhood hepatitis A vaccination. A literature review was performed in EMBASE, MEDLINE, WOPEC, HealthSTAR, SciELO and LILACS from 1995 to 2010. Most of the studies (8 of 10) showed favorable cost-effectiveness results. Sensitivity analysis indicated that the most important parameters for the results were cost of the vaccine, hepatitis A incidence, and medical costs of the disease. Variability was observed in methodological characteristics and estimates of key variables among the 10 studies reviewed. It is not possible to generalize results or transfer epidemiological estimates of resource utilization and costs associated with hepatitis A to the local context. Systematic review of economic evaluation studies of hepatitis A vaccine demonstrated the need for a national analysis and provided input for the development of a new decision-making model for Brazil.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2012-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000200002Cadernos de Saúde Pública v.28 n.2 2012reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/S0102-311X2012000200002info:eu-repo/semantics/openAccessDe Soárez,Patrícia CoelhoSartori,Ana Marli ChristovamSantos,AndreiaItria,AlexanderNovaes,Hillegonda Maria DutilhMartelli,Celina Maria Turchieng2012-02-13T00:00:00Zoai:scielo:S0102-311X2012000200002Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2012-02-13T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
title |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
spellingShingle |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil De Soárez,Patrícia Coelho Cost-Effectiveness Evaluation Cost-Benefit Analysis Hepatitis A Immunization Programs |
title_short |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
title_full |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
title_fullStr |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
title_full_unstemmed |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
title_sort |
Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil |
author |
De Soárez,Patrícia Coelho |
author_facet |
De Soárez,Patrícia Coelho Sartori,Ana Marli Christovam Santos,Andreia Itria,Alexander Novaes,Hillegonda Maria Dutilh Martelli,Celina Maria Turchi |
author_role |
author |
author2 |
Sartori,Ana Marli Christovam Santos,Andreia Itria,Alexander Novaes,Hillegonda Maria Dutilh Martelli,Celina Maria Turchi |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
De Soárez,Patrícia Coelho Sartori,Ana Marli Christovam Santos,Andreia Itria,Alexander Novaes,Hillegonda Maria Dutilh Martelli,Celina Maria Turchi |
dc.subject.por.fl_str_mv |
Cost-Effectiveness Evaluation Cost-Benefit Analysis Hepatitis A Immunization Programs |
topic |
Cost-Effectiveness Evaluation Cost-Benefit Analysis Hepatitis A Immunization Programs |
description |
The aim of this study was to present the contributions of the systematic review of economic evaluations to the development of a national study on childhood hepatitis A vaccination. A literature review was performed in EMBASE, MEDLINE, WOPEC, HealthSTAR, SciELO and LILACS from 1995 to 2010. Most of the studies (8 of 10) showed favorable cost-effectiveness results. Sensitivity analysis indicated that the most important parameters for the results were cost of the vaccine, hepatitis A incidence, and medical costs of the disease. Variability was observed in methodological characteristics and estimates of key variables among the 10 studies reviewed. It is not possible to generalize results or transfer epidemiological estimates of resource utilization and costs associated with hepatitis A to the local context. Systematic review of economic evaluation studies of hepatitis A vaccine demonstrated the need for a national analysis and provided input for the development of a new decision-making model for Brazil. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000200002 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000200002 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0102-311X2012000200002 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
dc.source.none.fl_str_mv |
Cadernos de Saúde Pública v.28 n.2 2012 reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1754115732100087808 |